Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision
- PMID: 17629481
- DOI: 10.1016/j.breast.2007.04.005
Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision
Abstract
Lobular neoplasia (LN) is a risk factor for bilateral breast cancer without consensus as to its appropriate management. The authors report on a retrospective multi-institutional study concerning 52 patients in whom a diagnosis of LN was made after core needle biopsy (CNB) and who subsequently underwent surgical excision. The excision specimens revealed seven cases of invasive carcinoma and three cases of ductal carcinoma in situ, indicating an underestimation of lesions at CNB in 19% of cases, and in particular in those patients with pleomorphic LN, and when clinical, radiological masses were detected. This lesion is increasingly being diagnosed by CNB due to widespread screening. Follow-up surgical excision should be performed in order to examine the whole lesion in the case of masses or when the histologic specimen reveals a pleomorphic subtype. In other cases, annual mammographic surveillance should be undertaken due to the persistent long-term risk of developing bilateral breast cancer.
Similar articles
-
Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.Am J Clin Pathol. 2006 Aug;126(2):310-3. doi: 10.1309/GT45-3DBM-LRNP-NKL2. Am J Clin Pathol. 2006. PMID: 16891208
-
Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?Mod Pathol. 2003 Feb;16(2):120-9. doi: 10.1097/01.MP.0000051930.68104.92. Mod Pathol. 2003. PMID: 12591964
-
Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?Diagn Cytopathol. 2003 Jun;28(6):329-34. doi: 10.1002/dc.10251. Diagn Cytopathol. 2003. PMID: 12768640
-
Lobular neoplasia: is surgical excision warranted?Am Surg. 2008 Feb;74(2):172-7. Am Surg. 2008. PMID: 18306873 Review.
-
Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.Eur J Surg Oncol. 2011 Apr;37(4):279-89. doi: 10.1016/j.ejso.2011.01.009. Eur J Surg Oncol. 2011. PMID: 21306860 Review.
Cited by
-
How Do We Approach Benign Proliferative Lesions?Curr Oncol Rep. 2018 Mar 23;20(4):34. doi: 10.1007/s11912-018-0682-1. Curr Oncol Rep. 2018. PMID: 29572753 Review.
-
Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.Oncol Lett. 2016 Dec;12(6):4863-4868. doi: 10.3892/ol.2016.5331. Epub 2016 Nov 1. Oncol Lett. 2016. PMID: 28105193 Free PMC article.
-
American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.Ann Diagn Pathol. 2020 Apr;45:151481. doi: 10.1016/j.anndiagpath.2020.151481. Epub 2020 Feb 15. Ann Diagn Pathol. 2020. PMID: 32120324 Free PMC article. Review.
-
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.Mod Pathol. 2020 Jun;33(6):1078-1091. doi: 10.1038/s41379-019-0449-8. Epub 2020 Jan 6. Mod Pathol. 2020. PMID: 31907376
-
Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?World J Clin Oncol. 2014 Aug 10;5(3):546-53. doi: 10.5306/wjco.v5.i3.546. World J Clin Oncol. 2014. PMID: 25114868 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical